Home Mauna Kea Technologies

Mauna Kea Technologies

First Published Report of Live “Tele-Cellvizio®” Utilization In Vivo between Surgeons and Remote Pathologists

This scientific publication, entitled "Intraoperative confocal laser endomicroscopy for real-time in vivo tissue characterization during surgical procedures", reports on outcomes of 21 consecutive patients that underwent laparoscopic surgery at the Institut Mutualiste Montsouris (IMM) in Paris, France, between 2014 and 2015.

Positive Results from Mayo Clinic Sponsored Prospective Multi-center Trial in Lung Transplant Patients

“The lung has the highest rate of acute rejection of any transplanted organ,” said Cesar Keller, M.D., Lung Transplant Program, Mayo Clinic, Jacksonville, Florida and first author of the study. “However, the current standard of care, transbronchial biopsy, requires multiple samples to be obtained per biopsy and carries a high risk of serious adverse events including pneumothorax and/or pulmonary bleeding. Considering the relatively frequent need to monitor these patients for acute rejection, better and less invasive methods to assess acute rejection would significantly improve patient care and outcomes.”

Cellvizio® Demonstrates Superior Identification of Patients at Risk for Esophageal Cancer Compared to Current Diagnostic Standard

Results from new clinical study that enrolled 172 patients at 8 non-academic centers in the United-States was presented at 2018 World Congress of Endoscopic Surgery hosted by SAGES and CAGS.

Mauna Kea Technologies: Largest Cellvizio Study To Date Demonstrates Near Perfect Correlation with Histology in Key GI Procedures

Mauna Kea Technologies inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy platform, today announced the presentation of...